ATP5PF and Hypertension: In hypertension study, intravenous injection of recombinant CF6 mimetics increased blood pressure transiently, apparently by suppressing PGI2 synthesis, whereas a specific antibody against CF6 decreased systemic blood pressure with a concomitant increase in plasma PGI2 in hypertension rats.